HEADER TRANSFERASE 11-MAY-00 1E1Y TITLE FLAVOPIRIDOL INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING AT THE TITLE 2 INHIBITOR SITE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN PHOSPHORYLASE, MUSCLE FORM; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MYOPHOSPHORYLASE; COMPND 5 EC: 2.4.1.1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 3 ORGANISM_COMMON: RABBIT; SOURCE 4 ORGANISM_TAXID: 9986; SOURCE 5 TISSUE: MUSCLE KEYWDS ALLOSTERIC INHIBITION, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR N.G.OIKONOMAKOS,S.E.ZOGRAPHOS,V.T.SKAMNAKI,K.E.TSITSANOU,L.N.JOHNSON REVDAT 11 06-DEC-23 1E1Y 1 HETSYN REVDAT 10 29-JUL-20 1E1Y 1 COMPND REMARK HETNAM SITE REVDAT 9 24-JUL-19 1E1Y 1 REMARK REVDAT 8 22-MAY-19 1E1Y 1 REMARK LINK REVDAT 7 31-AUG-11 1E1Y 1 HEADER COMPND SOURCE KEYWDS REVDAT 7 2 1 REMARK DBREF SEQADV HETSYN REVDAT 7 3 1 FORMUL VERSN REVDAT 6 24-FEB-09 1E1Y 1 VERSN REVDAT 5 24-JUN-03 1E1Y 1 REMARK HET HETNAM HETSYN REVDAT 5 2 1 FORMUL LINK SITE TER REVDAT 5 3 1 HETATM CONECT REVDAT 4 21-JUN-02 1E1Y 1 TITLE REVDAT 3 05-MAR-01 1E1Y 1 JRNL HET REVDAT 2 20-JUL-00 1E1Y 1 DBREF REVDAT 1 17-MAY-00 1E1Y 0 JRNL AUTH N.G.OIKONOMAKOS,J.B.SCHNIER,S.E.ZOGRAPHOS,V.T.SKAMNAKI, JRNL AUTH 2 K.E.TSITSANOU,L.N.JOHNSON JRNL TITL FLAVOPIRIDOL INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING AT JRNL TITL 2 THE INHIBITOR SITE JRNL REF J.BIOL.CHEM. V. 275 34566 2000 JRNL REFN ISSN 0021-9258 JRNL PMID 10924512 JRNL DOI 10.1074/JBC.M004485200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH N.G.OIKONOMAKOS,K.E.TSITSANOU,S.E.ZOGRAPHOS,V.T.SKAMNAKI, REMARK 1 AUTH 2 S.GOLDMANN,H.BISCHOFF REMARK 1 TITL ALLOSTERIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY THE REMARK 1 TITL 2 POTENTIAL ANTIDIABETIC DRUG 3-ISOPROPYL REMARK 1 TITL 3 4-(2-CHLOROPHENYL)-1,4-DIHYDRO-1-ETHYL-2-METHYL-PYRIDINE-3, REMARK 1 TITL 4 5,6-TRICARBOXYLATE REMARK 1 REF PROTEIN SCI. V. 8 1930 1999 REMARK 1 REFN ISSN 0961-8368 REMARK 1 PMID 10548038 REMARK 1 REFERENCE 2 REMARK 1 AUTH S.E.ZOGRAPHOS,N.G.OIKONOMAKOS,K.E.TSITSANOU,D.D.LEONIDAS, REMARK 1 AUTH 2 E.D.CHRYSINA,V.T.SKAMNAKI,H.BISCHOFF,S.GOLDMAN,M.SCHRAMM, REMARK 1 AUTH 3 K.A.WATSON,L.N.JOHNSON REMARK 1 TITL THE STRUCTURE OF GLYCOGEN PHOSPHORYLASE B WITH AN REMARK 1 TITL 2 ALKYL-DIHYDROPYRIDINE-DICARBOXYLIC ACID COMPOUND, A NOVEL REMARK 1 TITL 3 AND POTENT INHIBITOR REMARK 1 REF STRUCTURE V. 5 1413 1997 REMARK 1 REFN ISSN 0969-2126 REMARK 1 PMID 9384557 REMARK 1 DOI 10.1016/S0969-2126(97)00292-X REMARK 2 REMARK 2 RESOLUTION. 2.23 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.8 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.23 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 87.3 REMARK 3 NUMBER OF REFLECTIONS : 40691 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6617 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 59 REMARK 3 SOLVENT ATOMS : 644 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.240 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.650 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.500 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.000 ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : 1.500 ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.000 ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES WHERE OVERALL -FACTOR REMARK 3 VALUES EXCEED 60 A**2 INCLUDE 16-22 (71.1), 550-556 (69.4), AND REMARK 3 837-838 (75.9). TER PRO: RESIDUES 1-5,251-259,315-324,839- 842 REMARK 3 WERE NOT DEFINED BY ELECTRON DENSITY REMARK 4 REMARK 4 1E1Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-MAY-00. REMARK 100 THE DEPOSITION ID IS D_1290004949. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-00 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.70 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X13 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.05 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40691 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.230 REMARK 200 RESOLUTION RANGE LOW (A) : 29.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.3 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.10400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.23 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.43300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.8 REMARK 200 STARTING MODEL: PDB ENTRY 2GPA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AS DESCRIBED PREVIOUSLY BY OIKONOMAKOS REMARK 280 ET AL. (1999) PROTEIN SCIENCE 8, 1930-1945., PH 6.70 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.00900 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 63.37950 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 63.37950 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 87.01350 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 63.37950 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 63.37950 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 29.00450 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 63.37950 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 63.37950 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 87.01350 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 63.37950 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 63.37950 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 29.00450 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 58.00900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9920 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 56260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 116.01800 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2024 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 ARG A 2 REMARK 465 PRO A 3 REMARK 465 LEU A 4 REMARK 465 ASP A 251 REMARK 465 PHE A 252 REMARK 465 ASN A 253 REMARK 465 LEU A 254 REMARK 465 LYS A 255 REMARK 465 ASP A 256 REMARK 465 PHE A 257 REMARK 465 ASN A 258 REMARK 465 VAL A 259 REMARK 465 GLY A 260 REMARK 465 SER A 314 REMARK 465 LYS A 315 REMARK 465 PHE A 316 REMARK 465 GLY A 317 REMARK 465 CYS A 318 REMARK 465 ARG A 319 REMARK 465 ASP A 320 REMARK 465 PRO A 321 REMARK 465 VAL A 322 REMARK 465 ARG A 323 REMARK 465 THR A 324 REMARK 465 GLU A 839 REMARK 465 LYS A 840 REMARK 465 ILE A 841 REMARK 465 PRO A 842 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2012 O HOH A 2013 1.90 REMARK 500 NH1 ARG A 93 O HOH A 2092 1.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2018 O HOH A 2172 7556 1.93 REMARK 500 O HOH A 2039 O HOH A 2039 7556 2.04 REMARK 500 O HOH A 2018 O HOH A 2176 7556 2.04 REMARK 500 O HOH A 2220 O HOH A 2220 7555 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 6 -114.49 42.90 REMARK 500 ARG A 16 -74.65 -1.70 REMARK 500 LEU A 18 -167.05 -119.86 REMARK 500 ALA A 19 1.58 -53.08 REMARK 500 VAL A 21 1.70 -65.89 REMARK 500 GLU A 22 47.22 86.94 REMARK 500 VAL A 24 -60.55 -21.18 REMARK 500 LEU A 131 47.01 -84.87 REMARK 500 PHE A 166 153.74 -49.04 REMARK 500 TYR A 203 -129.27 61.85 REMARK 500 ARG A 234 24.49 49.63 REMARK 500 PRO A 281 25.62 -78.92 REMARK 500 ASP A 339 -170.19 77.64 REMARK 500 THR A 466 -108.91 -126.31 REMARK 500 ASN A 484 173.45 -54.29 REMARK 500 ARG A 489 -71.51 -70.05 REMARK 500 LEU A 492 -69.74 -158.08 REMARK 500 ASP A 514 61.70 -170.55 REMARK 500 ASN A 560 57.98 -103.96 REMARK 500 LYS A 568 172.20 178.22 REMARK 500 SER A 674 -57.93 -148.45 REMARK 500 SER A 751 60.66 -161.88 REMARK 500 HIS A 768 42.32 -140.50 REMARK 500 ASN A 793 79.55 -118.03 REMARK 500 PRO A 837 -52.26 -23.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2070 DISTANCE = 6.71 ANGSTROMS REMARK 525 HOH A2277 DISTANCE = 6.15 ANGSTROMS REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GPA RELATED DB: PDB REMARK 900 RELATED ID: 2GPA RELATED DB: PDB REMARK 900 RELATED ID: 1GPB RELATED DB: PDB REMARK 900 RELATED ID: 2GPB RELATED DB: PDB REMARK 900 RELATED ID: 3GPB RELATED DB: PDB REMARK 900 RELATED ID: 4GPB RELATED DB: PDB REMARK 900 RELATED ID: 5GPB RELATED DB: PDB REMARK 900 RELATED ID: 6GPB RELATED DB: PDB REMARK 900 RELATED ID: 7GPB RELATED DB: PDB REMARK 900 RELATED ID: 8GPB RELATED DB: PDB REMARK 900 RELATED ID: 9GPB RELATED DB: PDB REMARK 900 RELATED ID: 1ABB RELATED DB: PDB REMARK 900 RELATED ID: 1GPY RELATED DB: PDB REMARK 900 RELATED ID: 1NOI RELATED DB: PDB REMARK 900 RELATED ID: 1NOJ RELATED DB: PDB REMARK 900 RELATED ID: 1NOK RELATED DB: PDB REMARK 900 RELATED ID: 1PYG RELATED DB: PDB REMARK 900 RELATED ID: 2PRI RELATED DB: PDB REMARK 900 RELATED ID: 2PRJ RELATED DB: PDB REMARK 900 RELATED ID: 2AMV RELATED DB: PDB REMARK 900 RELATED ID: 3AMV RELATED DB: PDB REMARK 900 RELATED ID: 2SKC RELATED DB: PDB REMARK 900 RELATED ID: 2SKD RELATED DB: PDB REMARK 900 RELATED ID: 2SKE RELATED DB: PDB REMARK 900 RELATED ID: 1AXR RELATED DB: PDB REMARK 900 RELATED ID: 2GPN RELATED DB: PDB REMARK 900 RELATED ID: 1A8I RELATED DB: PDB REMARK 900 RELATED ID: 1BX3 RELATED DB: PDB REMARK 900 RELATED ID: 1B4D RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 2AMV SWALL P00489 1 - 13 NOT IN ATOMS LI REMARK 999 REMARK 999 REFERENCE: K.NAKANO, P.K.HWANG, R.J.FLETTERICK, FEBS REMARK 999 LETT., V. 204, P. 283, 1986. REMARK 999 REMARK 999 HIGH RESOLUTION DATA (1.5 ANGSTROMS) REFINEMENT ON T-STATE REMARK 999 GLYCOGEN PHOSPHORYLASE (UNPUBLISHED RESULTS) HAS CONFIRMED REMARK 999 THAT RESIDUE 609 IS INDEED ALA (NOT PRO). DBREF 1E1Y A 1 842 UNP P00489 PHS2_RABIT 2 843 SEQRES 1 A 842 SER ARG PRO LEU SER ASP GLN GLU LYS ARG LYS GLN ILE SEQRES 2 A 842 SER VAL ARG GLY LEU ALA GLY VAL GLU ASN VAL THR GLU SEQRES 3 A 842 LEU LYS LYS ASN PHE ASN ARG HIS LEU HIS PHE THR LEU SEQRES 4 A 842 VAL LYS ASP ARG ASN VAL ALA THR PRO ARG ASP TYR TYR SEQRES 5 A 842 PHE ALA LEU ALA HIS THR VAL ARG ASP HIS LEU VAL GLY SEQRES 6 A 842 ARG TRP ILE ARG THR GLN GLN HIS TYR TYR GLU LYS ASP SEQRES 7 A 842 PRO LYS ARG ILE TYR TYR LEU SER LEU GLU PHE TYR MET SEQRES 8 A 842 GLY ARG THR LEU GLN ASN THR MET VAL ASN LEU ALA LEU SEQRES 9 A 842 GLU ASN ALA CYS ASP GLU ALA THR TYR GLN LEU GLY LEU SEQRES 10 A 842 ASP MET GLU GLU LEU GLU GLU ILE GLU GLU ASP ALA GLY SEQRES 11 A 842 LEU GLY ASN GLY GLY LEU GLY ARG LEU ALA ALA CYS PHE SEQRES 12 A 842 LEU ASP SER MET ALA THR LEU GLY LEU ALA ALA TYR GLY SEQRES 13 A 842 TYR GLY ILE ARG TYR GLU PHE GLY ILE PHE ASN GLN LYS SEQRES 14 A 842 ILE CYS GLY GLY TRP GLN MET GLU GLU ALA ASP ASP TRP SEQRES 15 A 842 LEU ARG TYR GLY ASN PRO TRP GLU LYS ALA ARG PRO GLU SEQRES 16 A 842 PHE THR LEU PRO VAL HIS PHE TYR GLY ARG VAL GLU HIS SEQRES 17 A 842 THR SER GLN GLY ALA LYS TRP VAL ASP THR GLN VAL VAL SEQRES 18 A 842 LEU ALA MET PRO TYR ASP THR PRO VAL PRO GLY TYR ARG SEQRES 19 A 842 ASN ASN VAL VAL ASN THR MET ARG LEU TRP SER ALA LYS SEQRES 20 A 842 ALA PRO ASN ASP PHE ASN LEU LYS ASP PHE ASN VAL GLY SEQRES 21 A 842 GLY TYR ILE GLN ALA VAL LEU ASP ARG ASN LEU ALA GLU SEQRES 22 A 842 ASN ILE SER ARG VAL LEU TYR PRO ASN ASP ASN PHE PHE SEQRES 23 A 842 GLU GLY LYS GLU LEU ARG LEU LYS GLN GLU TYR PHE VAL SEQRES 24 A 842 VAL ALA ALA THR LEU GLN ASP ILE ILE ARG ARG PHE LYS SEQRES 25 A 842 SER SER LYS PHE GLY CYS ARG ASP PRO VAL ARG THR ASN SEQRES 26 A 842 PHE ASP ALA PHE PRO ASP LYS VAL ALA ILE GLN LEU ASN SEQRES 27 A 842 ASP THR HIS PRO SER LEU ALA ILE PRO GLU LEU MET ARG SEQRES 28 A 842 VAL LEU VAL ASP LEU GLU ARG LEU ASP TRP ASP LYS ALA SEQRES 29 A 842 TRP GLU VAL THR VAL LYS THR CYS ALA TYR THR ASN HIS SEQRES 30 A 842 THR VAL LEU PRO GLU ALA LEU GLU ARG TRP PRO VAL HIS SEQRES 31 A 842 LEU LEU GLU THR LEU LEU PRO ARG HIS LEU GLN ILE ILE SEQRES 32 A 842 TYR GLU ILE ASN GLN ARG PHE LEU ASN ARG VAL ALA ALA SEQRES 33 A 842 ALA PHE PRO GLY ASP VAL ASP ARG LEU ARG ARG MET SER SEQRES 34 A 842 LEU VAL GLU GLU GLY ALA VAL LYS ARG ILE ASN MET ALA SEQRES 35 A 842 HIS LEU CYS ILE ALA GLY SER HIS ALA VAL ASN GLY VAL SEQRES 36 A 842 ALA ARG ILE HIS SER GLU ILE LEU LYS LYS THR ILE PHE SEQRES 37 A 842 LYS ASP PHE TYR GLU LEU GLU PRO HIS LYS PHE GLN ASN SEQRES 38 A 842 LYS THR ASN GLY ILE THR PRO ARG ARG TRP LEU VAL LEU SEQRES 39 A 842 CYS ASN PRO GLY LEU ALA GLU ILE ILE ALA GLU ARG ILE SEQRES 40 A 842 GLY GLU GLU TYR ILE SER ASP LEU ASP GLN LEU ARG LYS SEQRES 41 A 842 LEU LEU SER TYR VAL ASP ASP GLU ALA PHE ILE ARG ASP SEQRES 42 A 842 VAL ALA LYS VAL LYS GLN GLU ASN LYS LEU LYS PHE ALA SEQRES 43 A 842 ALA TYR LEU GLU ARG GLU TYR LYS VAL HIS ILE ASN PRO SEQRES 44 A 842 ASN SER LEU PHE ASP VAL GLN VAL LYS ARG ILE HIS GLU SEQRES 45 A 842 TYR LYS ARG GLN LEU LEU ASN CYS LEU HIS VAL ILE THR SEQRES 46 A 842 LEU TYR ASN ARG ILE LYS LYS GLU PRO ASN LYS PHE VAL SEQRES 47 A 842 VAL PRO ARG THR VAL MET ILE GLY GLY LYS ALA ALA PRO SEQRES 48 A 842 GLY TYR HIS MET ALA LYS MET ILE ILE LYS LEU ILE THR SEQRES 49 A 842 ALA ILE GLY ASP VAL VAL ASN HIS ASP PRO VAL VAL GLY SEQRES 50 A 842 ASP ARG LEU ARG VAL ILE PHE LEU GLU ASN TYR ARG VAL SEQRES 51 A 842 SER LEU ALA GLU LYS VAL ILE PRO ALA ALA ASP LEU SER SEQRES 52 A 842 GLU GLN ILE SER THR ALA GLY THR GLU ALA SER GLY THR SEQRES 53 A 842 GLY ASN MET LYS PHE MET LEU ASN GLY ALA LEU THR ILE SEQRES 54 A 842 GLY THR MET ASP GLY ALA ASN VAL GLU MET ALA GLU GLU SEQRES 55 A 842 ALA GLY GLU GLU ASN PHE PHE ILE PHE GLY MET ARG VAL SEQRES 56 A 842 GLU ASP VAL ASP ARG LEU ASP GLN ARG GLY TYR ASN ALA SEQRES 57 A 842 GLN GLU TYR TYR ASP ARG ILE PRO GLU LEU ARG GLN ILE SEQRES 58 A 842 ILE GLU GLN LEU SER SER GLY PHE PHE SER PRO LYS GLN SEQRES 59 A 842 PRO ASP LEU PHE LYS ASP ILE VAL ASN MET LEU MET HIS SEQRES 60 A 842 HIS ASP ARG PHE LYS VAL PHE ALA ASP TYR GLU GLU TYR SEQRES 61 A 842 VAL LYS CYS GLN GLU ARG VAL SER ALA LEU TYR LYS ASN SEQRES 62 A 842 PRO ARG GLU TRP THR ARG MET VAL ILE ARG ASN ILE ALA SEQRES 63 A 842 THR SER GLY LYS PHE SER SER ASP ARG THR ILE ALA GLN SEQRES 64 A 842 TYR ALA ARG GLU ILE TRP GLY VAL GLU PRO SER ARG GLN SEQRES 65 A 842 ARG LEU PRO ALA PRO ASP GLU LYS ILE PRO HET CPB A 940 28 HET PO3 A 997 4 HET GLC A 998 12 HET PLP A 999 15 HETNAM CPB 2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1- HETNAM 2 CPB METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE HETNAM PO3 PHOSPHITE ION HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM PLP PYRIDOXAL-5'-PHOSPHATE HETSYN CPB FLAVOPIRIDOL HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN PLP VITAMIN B6 PHOSPHATE FORMUL 2 CPB C21 H20 CL N O5 FORMUL 3 PO3 O3 P 3- FORMUL 4 GLC C6 H12 O6 FORMUL 5 PLP C8 H10 N O6 P FORMUL 6 HOH *644(H2 O) HELIX 1 1 SER A 5 ILE A 13 5 9 HELIX 2 2 ASN A 23 THR A 38 1 16 HELIX 3 3 THR A 47 ASP A 78 1 32 HELIX 4 4 THR A 94 LEU A 102 1 9 HELIX 5 5 LEU A 104 LEU A 115 1 12 HELIX 6 6 ASP A 118 GLU A 124 1 7 HELIX 7 7 GLY A 134 LEU A 150 1 17 HELIX 8 8 PRO A 194 THR A 197 5 4 HELIX 9 9 GLY A 261 ASP A 268 1 8 HELIX 10 10 ARG A 269 ASN A 274 1 6 HELIX 11 11 ILE A 275 ARG A 277 5 3 HELIX 12 12 LYS A 289 SER A 313 1 25 HELIX 13 13 ALA A 328 LYS A 332 1 5 HELIX 14 14 LEU A 344 LEU A 356 1 13 HELIX 15 15 ASP A 360 THR A 371 1 12 HELIX 16 16 LEU A 380 LEU A 384 5 5 HELIX 17 17 VAL A 389 LEU A 396 1 8 HELIX 18 18 LEU A 396 PHE A 418 1 23 HELIX 19 19 ASP A 421 SER A 429 1 9 HELIX 20 20 MET A 441 GLY A 448 1 8 HELIX 21 21 ALA A 456 THR A 466 1 11 HELIX 22 22 PHE A 468 GLU A 475 1 8 HELIX 23 23 SER A 5 CYS A 495 1 470 HELIX 24 24 ASN A 496 GLY A 508 1 13 HELIX 25 25 GLU A 509 ASP A 514 5 6 HELIX 26 26 ASP A 514 VAL A 525 5 12 HELIX 27 27 ASP A 527 LYS A 554 1 28 HELIX 28 28 ARG A 575 GLU A 593 1 19 HELIX 29 29 TYR A 613 ASN A 631 1 19 HELIX 30 30 VAL A 636 ASP A 638 5 3 HELIX 31 31 ARG A 649 ILE A 657 1 9 HELIX 32 32 PRO A 658 ALA A 660 5 3 HELIX 33 33 THR A 676 ASN A 684 1 9 HELIX 34 34 ALA A 695 GLY A 704 1 10 HELIX 35 35 GLU A 705 PHE A 708 5 4 HELIX 36 36 ARG A 714 GLY A 725 1 12 HELIX 37 37 ASN A 727 ILE A 735 1 9 HELIX 38 38 ILE A 735 GLY A 748 1 14 HELIX 39 39 PHE A 758 HIS A 768 1 11 HELIX 40 40 LYS A 772 LYS A 792 1 21 HELIX 41 41 ASN A 793 ALA A 806 1 14 HELIX 42 42 THR A 807 PHE A 811 5 5 HELIX 43 43 SER A 812 ILE A 824 1 13 SHEET 1 A 3 LYS A 191 ALA A 192 0 SHEET 2 A 3 GLN A 219 PRO A 231 -1 O ASP A 227 N LYS A 191 SHEET 3 A 3 LEU A 198 PHE A 202 -1 O LEU A 198 N ALA A 223 SHEET 1 A1 9 LYS A 191 ALA A 192 0 SHEET 2 A1 9 GLN A 219 PRO A 231 -1 O ASP A 227 N LYS A 191 SHEET 3 A1 9 VAL A 238 LYS A 247 -1 O ASN A 239 N VAL A 230 SHEET 4 A1 9 ALA A 154 ILE A 159 1 O ALA A 154 N THR A 240 SHEET 5 A1 9 ARG A 81 LEU A 85 1 O ILE A 82 N TYR A 155 SHEET 6 A1 9 VAL A 333 ASN A 338 1 O ALA A 334 N TYR A 83 SHEET 7 A1 9 CYS A 372 THR A 375 1 O ALA A 373 N LEU A 337 SHEET 8 A1 9 VAL A 452 GLY A 454 1 N ASN A 453 O TYR A 374 SHEET 9 A1 9 PHE A 479 ASN A 481 1 O GLN A 480 N GLY A 454 SHEET 1 B 2 ASN A 167 CYS A 171 0 SHEET 2 B 2 TRP A 174 GLU A 178 -1 O TRP A 174 N CYS A 171 SHEET 1 C 2 ARG A 205 THR A 209 0 SHEET 2 C 2 GLY A 212 VAL A 216 -1 O GLY A 212 N THR A 209 SHEET 1 D 3 ARG A 386 PRO A 388 0 SHEET 2 D 3 ARG A 438 ASN A 440 -1 O ILE A 439 N TRP A 387 SHEET 3 D 3 VAL A 431 GLU A 432 -1 O GLU A 432 N ARG A 438 SHEET 1 E 6 LEU A 640 LEU A 645 0 SHEET 2 E 6 ARG A 601 GLY A 606 1 O ARG A 601 N ARG A 641 SHEET 3 E 6 LEU A 562 VAL A 567 1 O LEU A 562 N THR A 602 SHEET 4 E 6 LEU A 662 GLN A 665 1 O LEU A 662 N VAL A 565 SHEET 5 E 6 LEU A 687 GLY A 690 1 O LEU A 687 N SER A 663 SHEET 6 E 6 PHE A 709 ILE A 710 1 O PHE A 709 N GLY A 690 LINK OG SER A 14 P PO3 A 997 1555 1555 1.60 LINK NZ LYS A 680 C4A PLP A 999 1555 1555 1.34 CRYST1 126.759 126.759 116.018 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007889 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007889 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008619 0.00000